Wait Before Increasing Risperidone Dose
After only 3 days on risperidone 2 mg with improving symptoms, you should NOT increase the dose yet—continue the current dose and reassess after 14-21 days. 1
Rationale for Waiting
The International Clinical Practice Guidelines for Early Psychosis explicitly state that "the dose of the antipsychotic should be increased only at widely spaced intervals (after initial titration, usually 14–21 days) if the response has been inadequate." 1 This is critical because:
- Low doses take time to work: Antipsychotic medications do not have rapid effects on psychotic symptoms, and adequate trials require patience 1
- Your patient is already improving: Since symptoms are getting better, there is no indication for dose escalation
- Risk of unnecessary side effects: Premature dose increases expose patients to extrapyramidal symptoms (EPS) without additional benefit
Optimal Dosing Strategy
Target Dose Range
The FDA label and clinical guidelines converge on 2-4 mg/day as the optimal therapeutic range for most patients with schizophrenia:
- FDA-approved initial target: 2 mg/day for adults with schizophrenia, with a recommended range of 4-8 mg/day 2
- Clinical evidence: Research consistently shows 2 mg/day is effective in first-episode psychosis, with no significant difference in efficacy between 2 mg and 4 mg doses 3
- Guideline consensus: International guidelines recommend risperidone 2 mg/day as an appropriate initial target dose 1
When to Consider Dose Increases
Only increase the dose if:
- After 14-21 days, positive symptoms remain significant
- The patient tolerates the current dose without problematic side effects
- You've ruled out non-adherence or other factors affecting response
Dose escalation parameters:
- Increase in 1-2 mg increments at intervals of 24 hours or greater 2
- Maximum effective dose is typically 4-6 mg/day—doses above 6 mg show no additional efficacy and increase EPS risk 4, 5, 6
- The 2 mg dose in your patient is already within the therapeutic range
Critical Pitfalls to Avoid
1. Premature Dose Escalation
The most common error is increasing doses too quickly before allowing adequate time for response. Research shows patients on 2-4 mg/day have better discharge rates than those on 6 mg/day 7, suggesting lower doses may actually optimize outcomes.
2. Exceeding 6 mg/day
Multiple studies demonstrate that doses above 6 mg/day provide no additional benefit and significantly increase movement disorders 5, 6. The FDA label notes that "doses above 6 mg per day for twice daily dosing were not demonstrated to be more efficacious than lower doses, were associated with more extrapyramidal symptoms" 2.
3. Ignoring EPS Risk
Even at 2 mg/day, risperidone can cause extrapyramidal symptoms 4. The risk increases substantially at higher doses, particularly above 6 mg/day 1. Monitor for:
- Akathisia (restlessness)
- Parkinsonism (rigidity, tremor)
- Dystonia (muscle spasms)
Monitoring During This Period
While maintaining the 2 mg dose over the next 2-3 weeks:
- Assess symptom response using standardized scales (PANSS, CGI)
- Monitor for EPS even at this low dose
- Check for sedation/somnolence (common at all doses)
- Evaluate tolerability before any dose adjustment
Special Populations
- First-episode psychosis: 2 mg/day is particularly appropriate and well-studied 8, 3
- Elderly or hepatic/renal impairment: Start even lower (0.5 mg BID) and titrate more slowly 2
- Delirium management: Initial doses of 0.5 mg are recommended 9, 10
Bottom Line
Your patient is on an appropriate dose (2 mg/day), is showing improvement, and has only been on treatment for 3 days. The evidence strongly supports continuing this dose for at least 2-3 weeks before considering any increase. If you do need to increase later, 4 mg/day would be the next target, but many patients respond adequately to 2 mg/day, especially in first-episode presentations.